Detalles de la búsqueda
1.
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary.
Future Oncol
; : 1-14, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38501262
2.
A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors.
Clin Ther
; 46(3): 228-238, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38423866
3.
Progression-free survival and safety at 3.5years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer.
Eur J Cancer
; 189: 112908, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37263896
Resultados
1 -
3
de 3
1
Próxima >
>>